Mankind Pharma Limited — Moxifloxacin Exporter Profile
Indian Pharmaceutical Exporter · #10 for Moxifloxacin · $452.0K export value · DGFT Verified
Mankind Pharma Limited is the #10 Indian exporter of Moxifloxacin with $452.0K in export value and 11 verified shipments. Mankind Pharma Limited holds a 1.4% market share in Moxifloxacin exports across 2 countries. The company exports 15 pharmaceutical products worth $58.3M across 10 therapeutic categories.
Mankind Pharma Limited — Moxifloxacin Export Profile: Buyers & Destinations
Where Does Mankind Pharma Limited Export Moxifloxacin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $366.9K | 10 | 91.8% |
| PAKISTAN | $32.7K | 1 | 8.2% |
Mankind Pharma Limited exports Moxifloxacin to 2 countries. The largest destination is UNITED STATES accounting for 91.8% of Mankind Pharma Limited's Moxifloxacin shipments. These destinations reflect Mankind Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Moxifloxacin from Mankind Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| LIFESTAR PHARMA LLC | UNITED STATES | $266.9K | 8 |
| LIFESTAR PHARMA LLC.... | UNITED STATES | $100.0K | 2 |
| ZAHIR HADROGUL LTD. | PAKISTAN | $32.7K | 1 |
Mankind Pharma Limited supplies Moxifloxacin to 3 buyers globally. The largest buyer is LIFESTAR PHARMA LLC (UNITED STATES), followed by LIFESTAR PHARMA LLC.... (UNITED STATES) and ZAHIR HADROGUL LTD. (PAKISTAN). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Moxifloxacin Export Value and How Much Does Mankind Pharma Limited Contribute?
India exported $14.3M worth of Moxifloxacin through 2,413 shipments from 336 suppliers to 137 countries, serving 731 buyers globally. Mankind Pharma Limited contributes $452.0K to this total, accounting for 1.4% of India's Moxifloxacin exports. Mankind Pharma Limited ships Moxifloxacin to 2 countries through 3 buyers.
What Is the Average Shipment Value for Mankind Pharma Limited's Moxifloxacin Exports?
Mankind Pharma Limited's average Moxifloxacin shipment value is $41.1K per consignment, based on 11 shipments totaling $452.0K. The largest destination is UNITED STATES (91.8% of Mankind Pharma Limited's Moxifloxacin exports).
How Does Mankind Pharma Limited Compare to Other Indian Moxifloxacin Exporters?
Mankind Pharma Limited ranks #10 among 336 Indian Moxifloxacin exporters with a 1.4% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($2.3M), MICRO LABS LIMITED ($2.3M), EUGIA PHARMA SPECIALITIES LIMITED ($1.9M). Mankind Pharma Limited processed 11 shipments to 2 destination countries.
What Moxifloxacin Formulations Does Mankind Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% Batch No. AU7Y003 Mfg.Date JAN-2025 Exp Date DEC-2026 | $116.5K | 3 |
| Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% Batch No. AU7Y002 Mfg.Date DEC-2024 Exp Date NOV-2026 | $100.0K | 2 |
| Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% Batch No. AU7Y001 Mfg.Date DEC-2024 Exp Date NOV-2026 | $59.7K | 2 |
| Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% Batch No. AU7Y004 Mfg.Date JAN-2025 Exp Date DEC-2026 | $50.0K | 1 |
| Mahaflox-400 Tabs 1x5's {Each Film Coated Tablet Contains: Moxifloxacin Hydrochloride Equivalent to Moxifloxacin Batch N | $32.7K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP, 0.5% [BATCH NO. AU7Y006 MFG.DT. 02/25 EXP DT. 01/27] | $21.6K | 1 |
| MOXIFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION USP, 0.5% [BATCH NO. AU7Y005 MFG.DT. 02/25 EXP DT. 01/27] | $19.2K | 1 |
Mankind Pharma Limited exports 7 distinct Moxifloxacin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% Bat with 3 shipments worth $116.5K.
Regulatory Requirements: Exporting Moxifloxacin to Key Markets
What Mankind Pharma Limited must comply with to export Moxifloxacin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Mankind Pharma Limited Compare to Nearest Moxifloxacin Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | ALEMBIC PHARMACEUTICALS LIMITED | $683.8K | 25 | 1 | $27.4K |
| 9 | MACLEODS PHARMACEUTICALS LIMITED | $656.3K | 20 | 10 | $32.8K |
| 10 | MANKIND PHARMA LIMITED ★ | $452.0K | 11 | 2 | $41.1K |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $401.3K | 15 | 6 | $26.8K |
| 13 | HETERO LABS LIMITED | $260.9K | 7 | 3 | $37.3K |
Mankind Pharma Limited ranks #10 among 336 Indian Moxifloxacin exporters. Average shipment value of $41.1K compared to the market average of $42.4K. The closest competitors by value are ALEMBIC PHARMACEUTICALS LIMITED and MACLEODS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Moxifloxacin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 311 | 12.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 263 | 10.9% |
| DELHI AIR CARGO ACC (INDEL4) | 152 | 6.3% |
| DELHI AIR | 132 | 5.5% |
| NHAVA SHEVA SEA (INNSA1) | 126 | 5.2% |
| Bombay Air | 119 | 4.9% |
| CHENNAI AIR | 111 | 4.6% |
| CHENNAI AIR CARGO ACC (INMAA4) | 93 | 3.9% |
What Other Advanced Antibiotics Products Does Mankind Pharma Limited Export?
Mankind Pharma Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Mankind Pharma Limited's Moxifloxacin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Mankind Pharma. The Israel-Iran conflict has led to increased tensions in the Red Sea, resulting in higher shipping costs and potential delays for exporters relying on these routes. Additionally, Houthi attacks in the region have further exacerbated shipping disruptions, impacting the timely delivery of pharmaceutical products.
Conversely, ongoing US-China trade tensions have prompted the United States to diversify its import sources, creating opportunities for Indian pharmaceutical companies to capture a larger share of the US market. Mankind Pharma's established presence and compliance with international quality standards position it favorably to leverage this shift.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, necessitate robust compliance measures. Mankind Pharma's commitment to quality and recent strategic initiatives, including the acquisition of BSV, enhance its ability to meet these evolving standards and maintain a competitive edge in the EU market.
Mankind Pharma Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Mankind Pharma's adherence to guidelines set by the FDA, WHO, and EU GMP underscores its commitment to quality. The acquisition of BSV, known for its complex R&D platforms and biologics expertise, further strengthens Mankind Pharma's compliance capabilities, ensuring alignment with global quality requirements. (mankindpharma.com)
The evolving regulatory landscape, particularly in the EU with directives like the Falsified Medicines Directive, demands continuous adaptation. Mankind Pharma's proactive approach, including investments in advanced manufacturing and quality assurance systems, positions it well to navigate these changes and sustain its export growth.
About Mankind Pharma Limited
Mankind Pharma Limited exports 15 products worth $58.3M. Beyond Moxifloxacin, top products include Nitrofurantoin, Formoterol, Phenylephrine, Ofloxacin, Vati. View the complete Mankind Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Moxifloxacin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Moxifloxacin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Mankind Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 11 individual customs records matching Mankind Pharma Limited exporting Moxifloxacin, covering 7 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Moxifloxacin Export Data from Mankind Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Mankind Pharma Limited's Moxifloxacin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Mankind Pharma Limited
Full Company Profile →
15 products · $58.3M total trade · 10 categories
Moxifloxacin Stats
Company Overview
Top Products by Mankind Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Mankind Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Moxifloxacin. For current shipment-level data, contact TransData Nexus.